Pérez-Belmonte, L.M.; Gómez-Doblas, J.J.; Millán-Gómez, M.; López-Carmona, M.D.; Guijarro-Merino, R.; Carrasco-Chinchilla, F.; De Teresa-Galván, E.; Jiménez-Navarro, M.; Bernal-López, M.R.; Gómez-Huelgas, R.
Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study). J. Clin. Med. 2018, 7, 271.
https://doi.org/10.3390/jcm7090271
AMA Style
Pérez-Belmonte LM, Gómez-Doblas JJ, Millán-Gómez M, López-Carmona MD, Guijarro-Merino R, Carrasco-Chinchilla F, De Teresa-Galván E, Jiménez-Navarro M, Bernal-López MR, Gómez-Huelgas R.
Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study). Journal of Clinical Medicine. 2018; 7(9):271.
https://doi.org/10.3390/jcm7090271
Chicago/Turabian Style
Pérez-Belmonte, Luis M., Juan J. Gómez-Doblas, Mercedes Millán-Gómez, María D. López-Carmona, Ricardo Guijarro-Merino, Fernando Carrasco-Chinchilla, Eduardo De Teresa-Galván, Manuel Jiménez-Navarro, M. Rosa Bernal-López, and Ricardo Gómez-Huelgas.
2018. "Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study)" Journal of Clinical Medicine 7, no. 9: 271.
https://doi.org/10.3390/jcm7090271
APA Style
Pérez-Belmonte, L. M., Gómez-Doblas, J. J., Millán-Gómez, M., López-Carmona, M. D., Guijarro-Merino, R., Carrasco-Chinchilla, F., De Teresa-Galván, E., Jiménez-Navarro, M., Bernal-López, M. R., & Gómez-Huelgas, R.
(2018). Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study). Journal of Clinical Medicine, 7(9), 271.
https://doi.org/10.3390/jcm7090271
